Epic Sciences
PrivateLast Round
Series G
Apr 14, 2023
Total Funding Raised
$208.2M
Company Overview
Epic Sciences is a biotechnology company that develops diagnostic tests for the rapid and non-invasive detection of genetic and molecular changes in cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epic Sciences Comparables
Compare Epic Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RareCyte | 84% | |
| CellMax Life | 80% | |
| QCDx | 79% | |
Epic Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series G | Apr 14, 2023 | ||||
| Series F | Jun 1, 2022 | ||||
| Series E | Sep 12, 2018 | ||||
| Series D | Apr 28, 2017 | ||||
| Series C | Jul 30, 2014 | ||||
Grant | Jan 25, 2013 |
Epic Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RusnanoMedInvest | Series C |
| Deerfield Management | Series E, Series F, Series G |
| National Cancer Institute | Grant |
| Roche Venture Fund | Series B, Series C |
| Genomic Health | Series E, Series D |
| Domain Associates | Series E, Series G, Series D, Series C, Series B |
| Altos Capital Partners | Series E, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2023
$24M round led by Arsenal Capital Partners and Deerfield Management.
- Jun 1, 2022
$43M round led by Arsenal Capital Partners.
Epic Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epic Sciences's valuation, stock price, and market status.